Related Experiment Video
Updated: Oct 5, 2025
09:43
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
3.1K
Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus
Gongjun Tan1, Binila Baby2, Yuqiu Zhou1
1Department of Clinical Laboratory, Zhuhai Maternal and Child Healthcare Hospital, Zhuhai, China.
Frontiers in Immunology
|January 31, 2022
Summary
New biomarkers show promise for diagnosing systemic lupus erythematosus (SLE), an autoimmune disease. Research reviews emerging Omics markers to improve lupus diagnosis and treatment monitoring.
Area of Science:
- Immunology
- Genetics
- Biomarker Discovery
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease with challenging diagnosis and treatment.
- Current diagnostic methods rely on clinical symptoms and lab tests with suboptimal sensitivity and specificity.
- There is a critical need for improved diagnostic tools for effective SLE management and drug development.
Purpose of the Study:
- To review the sensitivity, specificity, and diagnostic value of emerging biomarkers for SLE.
- To discuss the potential of these biomarkers in developing diagnostic panels and monitoring systems for SLE.
Main Methods:
- Literature review of recent studies on novel SLE biomarkers.
- Analysis of biomarkers from various bodily fluids, including blood, urine, and cerebrospinal fluid (CSF).
Main Results:
- Emerging Omics technologies have identified potential novel biomarkers for SLE.
- Individual biomarkers often lack sufficient sensitivity or specificity for clinical use.
- Many identified biomarkers require further validation for clinical application.
Conclusions:
- Biomarker panels hold potential for developing more accurate diagnostics and monitoring systems for SLE.
- Further validation of emerging biomarkers is crucial for clinical implementation.
- Advancements in Omics offer new avenues for understanding and managing SLE.
